Innovating Works
MIN4ALD: Use of MIN 102 for the treatment of children with cerebral ALD MINORYX THERAPEUTICS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 The objective of the MIN4ALD project is the development of a new pharmacological therapy to treat paediatric patients with cerebral ALD (cAL...
2018-09-05 - 2022-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.